Latest S-1 registration statements

Aclarion, Inc. is seeking to raise capital through a public offering of common stock and warrants, while also addressing ongoing compliance issues with Nasdaq listing requirements.

Cortigent, a neurostimulation technology company, is seeking to raise approximately $15 million through an initial public offering to fund the development of its Orion visual prosthesis and stroke recovery system.

Loar Holdings Inc. has filed an amended S-1 registration statement to increase the number of shares offered in its public offering by 1,150,000, including an underwriter option.

Tianci International, Inc. is planning a public offering of 2.17 million shares of common stock and a resale of 3.26 million shares, contingent upon Nasdaq listing approval.

Sacks Parente Golf, Inc. has filed an amendment to its registration statement for a public offering of common units, pre-funded units, and warrants.

Theriva Biologics is planning a public offering of up to 7,692,307 shares of common stock, along with warrants, to raise capital for working capital and general corporate purposes.

K&F Growth Acquisition Corp. II, a blank check company, has filed for a $250 million initial public offering, focusing on the experiential entertainment industry.

SOBR Safe, Inc. has filed an amended registration statement for the resale of up to 31,036,386 shares of common stock by selling securityholders, following a recent private placement.

HWH International Inc. has filed an amendment to its S-1 registration statement, detailing the terms of a proposed offering of common stock and pre-funded warrants.

Cosmos Health Inc. has filed an amendment to its registration statement for the resale of up to 9,748,252 shares of common stock issuable upon exercise of warrants, following a recent inducement offer.

Onconetix, Inc. has filed an amendment to its registration statement to facilitate the potential sale of up to 6,250,000 shares of common stock through an equity line of credit with Keystone Capital Partners, LLC.

Nordicus Partners Corporation has filed a registration statement for the resale of 16,190,911 shares of its common stock by existing shareholders.

Qualigen Therapeutics is registering for resale up to 3,436,281 shares of common stock issuable upon conversion of Series A-2 Preferred Stock held by selling stockholders.

NusaTrip Incorporated has filed an amendment to its Form S-1 registration statement, detailing its initial public offering and a secondary offering by selling stockholders.

JFB Construction Holdings has filed an amendment to its registration statement for an initial public offering of 1,250,000 units, each consisting of one share of Class A common stock and one warrant.

SmartStop Self Storage REIT has filed an amendment to its registration statement, detailing financial transactions, property acquisitions, and debt management activities.

Allurion Technologies, a medical device company focused on weight loss solutions, has filed a registration statement for a potential offering of up to $30 million in common stock, pre-funded warrants, and common warrants.

ServiceTitan, a cloud-based software platform for trades businesses, has filed for an initial public offering, seeking to capitalize on the underserved technology needs of the industry.

Momentus Inc. is seeking to raise up to $20.55 million through a mix of common stock, pre-funded warrants, and common warrants, as it navigates Nasdaq listing compliance issues.

Clinical-stage biopharmaceutical company Palisade Bio, Inc. is offering up to 2,857,142 Class A Units and Class B Units to raise capital for its Phase 1 clinical trial and other development activities.

Hennessy Capital Investment Corp. VII, a newly formed blank check company, has filed an amendment to its registration statement for a proposed $150 million initial public offering focused on industrial technology and energy transition sectors.

Kraig Biocraft Laboratories files an amendment to its registration statement to include updated financial information and details about a proposed public offering.

Drugs Made In America Acquisition Corp., a blank check company, filed an amendment to its S-1 registration statement for a proposed $200 million initial public offering.

ChampionsGate Acquisition Corporation, a blank check company, has filed for a $200 million initial public offering to pursue a merger, share exchange, asset acquisition, or similar business combination.

The Marquie Group, Inc. has filed an amendment to its S-1 registration statement, primarily to include updated exhibits.

Anteris Technologies Global Corp., a structural heart company, has filed for an initial public offering (IPO) in the U.S. to support the development and commercialization of its innovative DurAVR transcatheter heart valve system.

Apimeds Pharmaceuticals US, Inc. has filed an amendment to its registration statement for an initial public offering of its common stock, aiming to raise capital for clinical trials and operations.

Splash Beverage Group is registering for resale up to 82.9 million shares of common stock held by selling stockholders, primarily from convertible notes and warrants, while the company faces ongoing financial difficulties.

Loar Holdings Inc. has filed a registration statement for a secondary offering of 4,750,000 shares of its common stock, with 3,166,667 shares offered by the company and 1,583,333 shares offered by selling stockholders.

Falcons Beyond Global, a company focused on immersive entertainment experiences, has filed a registration statement for an offering of its Class A common stock.